First Time Loading...

Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 145.17 USD -0.19%
Updated: Jun 14, 2024
Have any thoughts about
Johnson & Johnson?
Write Note

Intrinsic Value

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. [ Read More ]

The intrinsic value of one JNJ stock under the Base Case scenario is 159.83 USD. Compared to the current market price of 145.17 USD, Johnson & Johnson is Undervalued by 9%.

Key Points:
JNJ Intrinsic Value
Base Case
159.83 USD
Undervaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Johnson & Johnson

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling JNJ stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Johnson & Johnson

Current Assets 57B
Cash & Short-Term Investments 26.2B
Receivables 14.9B
Other Current Assets 15.8B
Non-Current Assets 115B
Long-Term Investments 4.5B
PP&E 19.6B
Intangibles 70.9B
Other Non-Current Assets 19.9B
Current Liabilities 48.7B
Accounts Payable 8.2B
Accrued Liabilities 28.7B
Short-Term Debt 6.3B
Other Current Liabilities 5.6B
Non-Current Liabilities 53.2B
Long-Term Debt 25.1B
Other Non-Current Liabilities 28.1B
Efficiency

Earnings Waterfall
Johnson & Johnson

Revenue
85.6B USD
Cost of Revenue
-26.1B USD
Gross Profit
59.6B USD
Operating Expenses
-35.3B USD
Operating Income
24.3B USD
Other Expenses
14.2B USD
Net Income
38.5B USD

Free Cash Flow Analysis
Johnson & Johnson

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

JNJ Profitability Score
Profitability Due Diligence

Johnson & Johnson's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Exceptional ROE
71/100
Profitability
Score

Johnson & Johnson's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

JNJ Solvency Score
Solvency Due Diligence

Johnson & Johnson's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Positive Net Debt
64/100
Solvency
Score

Johnson & Johnson's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 175.39 USD with a low forecast of 156.55 USD and a high forecast of 225.75 USD.

Lowest
Price Target
156.55 USD
8% Upside
Average
Price Target
175.39 USD
21% Upside
Highest
Price Target
225.75 USD
56% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

JNJ Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

JNJ Price
Johnson & Johnson

1M 1M
-3%
6M 6M
-7%
1Y 1Y
-10%
3Y 3Y
-7%
5Y 5Y
+15%
10Y 10Y
+81%
Annual Price Range
145.17
52w Low
144.38
52w High
174.48
Price Metrics
Average Annual Return 8.71%
Standard Deviation of Annual Returns 3.1%
Max Drawdown -27%
Shares Statistics
Market Capitalization 348.9B USD
Shares Outstanding 2 406 680 064
Percentage of Shares Shorted 0.72%

JNJ Return Decomposition
Main factors of price return

What is price return decomposition?

JNJ News

Other Videos

Last Important Events
Johnson & Johnson

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Johnson & Johnson

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Johnson & Johnson Logo
Johnson & Johnson

Country

United States of America

Industry

Pharmaceuticals

Market Cap

348.9B USD

Dividend Yield

3.42%

Description

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in New Brunswick, New Jersey and currently employs 141,700 full-time employees. The firm operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Contact

NEW JERSEY
New Brunswick
One Johnson & Johnson Plaza
+17325242455.0
https://www.jnj.com/

IPO

1944-09-25

Employees

141 700

Officers

CEO & Chairman
Mr. Joaquin Duato
Executive VP & CFO
Mr. Joseph J. Wolk CPA
Executive VP & Chief Human Resources Officer
Dr. Peter M. Fasolo Ph.D.
Executive VP & Worldwide Chairman of Innovative Medicine
Ms. Jennifer L. Taubert
Executive Vice President of Innovative Medicine, R&D
Dr. John C. Reed M.D., Ph.D.
Controller & Chief Accounting Officer
Mr. Robert J. Decker Jr.
Show More
Executive VP & Chief Information Officer
Mr. James Swanson
Vice President of Investor Relations
Ms. Jessica Moore
Chief Compliance Officer
Mr. Dirk Brinckman
Executive VP & General Counsel
Ms. Elizabeth Forminard
Show Less

See Also

Discover More
What is the Intrinsic Value of one JNJ stock?

The intrinsic value of one JNJ stock under the Base Case scenario is 159.83 USD.

Is JNJ stock undervalued or overvalued?

Compared to the current market price of 145.17 USD, Johnson & Johnson is Undervalued by 9%.